NOVAREX Co.,Ltd. (KOSDAQ:194700)

South Korea flag South Korea · Delayed Price · Currency is KRW
20,300
+380 (1.91%)
At close: Aug 28, 2025
1.91%
Market Cap359.35B
Revenue (ttm)349.19B
Net Income (ttm)27.12B
Shares Out17.70M
EPS (ttm)1,532.00
PE Ratio13.25
Forward PEn/a
Dividend200.00 (1.00%)
Ex-Dividend DateDec 27, 2024
Volume178,808
Average Volume248,300
Open19,890
Previous Close19,920
Day's Range19,450 - 20,500
52-Week Range6,650 - 22,100
Beta0.31
RSI57.71
Earnings DateAug 11, 2025

About NOVAREX

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science Co., Ltd. and changed its name to NOVAREX Co.,Ltd. in November 2013. NOVAREX Co.,Ltd. was founded in 1995 and is headquartered in Cheongju-si, South Kor... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 436
Stock Exchange KOSDAQ
Ticker Symbol 194700
Full Company Profile

Financial Performance

In 2024, NOVAREX's revenue was 297.73 billion, a decrease of -1.47% compared to the previous year's 302.17 billion. Earnings were 23.02 billion, an increase of 4.45%.

Financial Statements

News

There is no news available yet.